Yin and yang: Immune signaling protein has opposing roles in breast cancer development

Countering previously held beliefs, researchers at The University of Texas MD Anderson Cancer Center have discovered that inhibiting the immune receptor protein TLR4 may not be a wise treatment strategy in all cancers. This is because TLR4 can either promote or inhibit breast cancer cell growth depending on mutations in a gene called TP53.
Source: M. D. Anderson Cancer Center - News Releases - Category: Cancer & Oncology Source Type: news